Frost & Sullivan

MARCH 28, 2025

The pharmaceutical and biotechnology industries are at the cusp of a transformative era in 2025, driven by cutting-edge innovation, evolving regulations, and increasing market pressures. Download our full analysis on the top 6 growth opportunities in pharma and biotech. By 2030, the RLT market is projected to reach $13.07

Biotech 52

Biotech Biotechnology Strategic partnership Insurance 52

Frost & Sullivan

MAY 9, 2025

billion by 2030. This article explores the key trends, market drivers, and emerging opportunities in the pharmaceutical clinical contract peripheral services market from 2024 to 2030. The global CRO industry, valued at $66.39 billion in 2024, is projected to grow at a CAGR of 10.7%, reaching $122.13

Mergers and acquisition activities 52

Mergers and acquisition activities Biopharma Biotechnology Biotech 52

Frost & Sullivan

MARCH 28, 2025

million by 2030, emphasizing the need for early and accurate diagnostics. Elabscience Biotechnology, Inc., Download our full analysis on Cardiac Biomarkers Diagnostics. Click here to download According to the World Health Organization (WHO), CVD-related deaths are projected to reach 23.3 Quanterix, Response Biomedical Corp.,

Biotechnology 52

Biotechnology Biotech Ecosystems 52